CARMUSTINE

Generic: CARMUSTINE

KVK-TechManufacturer
INTRAVENOUSRoute
2019-04-02Original Approval

CARMUSTINE is FDA application ANDA209278, sponsored by PENN LIFE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
OFF LABEL USE
510 reports
2
FEBRILE NEUTROPENIA
400 reports
3
MYELODYSPLASTIC SYNDROME
298 reports
4
DISEASE PROGRESSION
269 reports
5
MUCOSAL INFLAMMATION
256 reports
6
THROMBOCYTOPENIA
232 reports
7
PYREXIA
209 reports
8
NEUTROPENIA
206 reports
9
PNEUMONIA
199 reports
10
DRUG INEFFECTIVE
197 reports